MRI scans to track nerve damage in neuropathy patients
Part of Brain & nervous system, Genetic & congenital clinical trials.
This study uses MRI scans to look at nerve and muscle changes over time in people with inherited or acquired nerve conditions. It may help doctors better understand how these diseases progress.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have a confirmed genetic nerve condition (like CMT) or an acquired nerve disease (like PIDC or anti-MAG), or a TTR gene mutation
- You are able to have an MRI (no metal implants, pacemakers, or severe claustrophobia)
- You are not currently in another medical research study
- You can read and understand French well enough to give consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks for new markers of Charcot-Marie-Tooth 1A (CMT1A) early in the disease. Researchers hope to find signs that can help diagnose and track the disease better, which could lead to better treatments in the future.
This study uses advanced MRI scans to see if they can provide more detailed brain images for people with multiple sclerosis (MS) and healthy volunteers. The goal is to improve how doctors monitor MS and understand brain changes.
This study tests whether special MRI scans can help evaluate neuromuscular (muscle/nerve) diseases. It may help doctors better assess muscle involvement and support diagnosis and evaluation.
This study looks at how nerves work and their structure in people with Charcot-Marie-Tooth disease, CIDP, or anti-MAG neuropathy. It may help doctors better understand these conditions.
This study uses a very powerful MRI scanner (7T) to take detailed pictures of the brain and spinal cord in people with motor neuron disease. The goal is to find non-invasive markers that could help diagnose and monitor the disease.
This study looks for new markers of early Charcot-Marie-Tooth 1A (CMT1A) disease using blood tests and special MRI scans. It aims to help understand how the disease progresses and may lead to better treatments.
Hear when a new Charcot-Marie-Tooth Neuropathy Type 1A trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.